{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:19Z","timestamp":1786980259015,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00467-015-3173-8","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T01:59:44Z","timestamp":1439344784000},"page":"1267-1279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Platelet abnormalities in nephrotic syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Benedicte","family":"Eneman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Van Geet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Freson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"key":"3173_CR1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1749-6632.1999.tb08475.x","volume":"872","author":"K Kaushansky","year":"1999","unstructured":"Kaushansky K (1999) Thrombopoietin and hematopoietic stem cell development. Ann N Y Acad Sci 872:314\u2013319","journal-title":"Ann N Y Acad Sci"},{"key":"3173_CR2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(00)02175-9","volume":"355","author":"JN George","year":"2000","unstructured":"George JN (2000) Platelets. Lancet 355:1531\u20131539","journal-title":"Lancet"},{"key":"3173_CR3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2141.1984.tb06115.x","volume":"58","author":"AP Bautista","year":"1984","unstructured":"Bautista AP, Buckler PW, Towler HM, Dawson AA, Bennett B (1984) Measurement of platelet life-span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets. Br J Haematol 58:679\u2013687","journal-title":"Br J Haematol"},{"key":"3173_CR4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","volume":"22","author":"S Kamath","year":"2001","unstructured":"Kamath S, Blann AD, Lip GY (2001) Platelet activation: assessment and quantification. Eur Heart J 22:1561\u20131571","journal-title":"Eur Heart J"},{"key":"3173_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-29423-5_1","volume":"210","author":"JN Thon","year":"2012","unstructured":"Thon JN, Italiano JE (2012) Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol 210:3\u201322","journal-title":"Handb Exp Pharmacol"},{"key":"3173_CR6","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"M Gawaz","year":"2005","unstructured":"Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378\u20133384","journal-title":"J Clin Invest"},{"key":"3173_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","volume":"67","author":"JW Semple","year":"2010","unstructured":"Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67:499\u2013511","journal-title":"Cell Mol Life Sci"},{"key":"3173_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2005.12.005","volume":"238","author":"BD Elzey","year":"2005","unstructured":"Elzey BD, Sprague DL, Ratliff TL (2005) The emerging role of platelets in adaptive immunity. Cell Immunol 238:1\u20139","journal-title":"Cell Immunol"},{"key":"3173_CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","volume":"72","author":"M Bryckaert","year":"2015","unstructured":"Bryckaert M, Rosa JP, Denis CV, Lenting PJ (2015) Of von Willebrand factor and platelets. Cell Mol Life Sci 72:307\u2013326","journal-title":"Cell Mol Life Sci"},{"key":"3173_CR10","first-page":"456569","volume":"2014","author":"JL Choi","year":"2014","unstructured":"Choi JL, Li S, Han JY (2014) Platelet function tests: a review of progresses in clinical application. Biomed Res Int 2014:456569","journal-title":"Biomed Res Int"},{"key":"3173_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0163-7827(03)00025-0","volume":"42","author":"BR Lentz","year":"2003","unstructured":"Lentz BR (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 42:423\u2013438","journal-title":"Prog Lipid Res"},{"key":"3173_CR12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0005-2760(85)90152-3","volume":"834","author":"CM Skeaff","year":"1985","unstructured":"Skeaff CM, Holub BJ (1985) Altered phospholipid composition of plasma membranes from thrombin-stimulated human platelets. Biochim Biophys Acta 834:164\u2013171","journal-title":"Biochim Biophys Acta"},{"key":"3173_CR13","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/j.1538-7836.2005.01274.x","volume":"3","author":"GL Dale","year":"2005","unstructured":"Dale GL (2005) Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 3:2185\u20132192","journal-title":"J Thromb Haemost"},{"key":"3173_CR14","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2012-09-457739","volume":"121","author":"TJ Stalker","year":"2013","unstructured":"Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF (2013) Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 121:1875\u20131885","journal-title":"Blood"},{"key":"3173_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/107602960401000208","volume":"10","author":"V Wiwanitkit","year":"2004","unstructured":"Wiwanitkit V (2004) Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost 10:175\u2013178","journal-title":"Clin Appl Thromb Hemost"},{"key":"3173_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12231","author":"M Cattaneo","year":"2013","unstructured":"Cattaneo M, Cerletti C, Harrison P, Hayward CP, Kenny D, Nugent D, Nurden P, Rao AK, Schmaier AH, Watson SP, Lussana F, Pugliano MT, Michelson AD (2013) Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC\/ISTH. J Thromb Haemost. doi: 10.1111\/jth.12231","journal-title":"J Thromb Haemost"},{"key":"3173_CR17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","volume":"13","author":"P Gresele","year":"2015","unstructured":"Gresele P, Subcommittee on Platelet Physiology (2015) Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 13:314\u2013322","journal-title":"J Thromb Haemost"},{"key":"3173_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bcmd.2007.09.004","volume":"40","author":"M Kang","year":"2008","unstructured":"Kang M, Wilson L, Kermode JC (2008) Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Blood Cells Mol Dis 40:433\u2013443","journal-title":"Blood Cells Mol Dis"},{"key":"3173_CR19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199804233381707","volume":"338","author":"SR Orth","year":"1998","unstructured":"Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338:1202\u20131211","journal-title":"N Engl J Med"},{"key":"3173_CR20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","volume":"118","author":"R Singhal","year":"2006","unstructured":"Singhal R, Brimble KS (2006) Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 118:397\u2013407","journal-title":"Thromb Res"},{"key":"3173_CR21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","volume":"117","author":"BK Mahmoodi","year":"2008","unstructured":"Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J (2008) High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117:224\u2013230","journal-title":"Circulation"},{"key":"3173_CR22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE (2012) Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol 7:513\u2013520","journal-title":"Clin J Am Soc Nephrol"},{"key":"3173_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0049-3848(81)90171-7","volume":"23","author":"E Walter","year":"1981","unstructured":"Walter E, Deppermann D, Andrassy K, Koderisch J (1981) Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res 23:473\u2013479","journal-title":"Thromb Res"},{"key":"3173_CR24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1987.73","volume":"31","author":"A Robert","year":"1987","unstructured":"Robert A, Olmer M, Sampol J, Gugliotta JE, Casanova P (1987) Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int 31:830\u2013835","journal-title":"Kidney Int"},{"key":"3173_CR25","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ki.1989.310","volume":"36","author":"C Machleidt","year":"1989","unstructured":"Machleidt C, Mettang T, Starz E, Weber J, Risler T, Kuhlmann U (1989) Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome. Kidney Int 36:1119\u20131124","journal-title":"Kidney Int"},{"key":"3173_CR26","first-page":"182","volume":"27","author":"A Bennett","year":"1987","unstructured":"Bennett A, Cameron JS (1987) Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. Clin Nephrol 27:182\u2013188","journal-title":"Clin Nephrol"},{"key":"3173_CR27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH11-09-0673","volume":"107","author":"C Gao","year":"2012","unstructured":"Gao C, Xie R, Yu C, Wang Q, Shi F, Yao C, Xie R, Zhou J, Gilbert GE, Shi J (2012) Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 107:681\u2013689","journal-title":"Thromb Haemost"},{"key":"3173_CR28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000188254","volume":"68","author":"E Andre","year":"1994","unstructured":"Andre E, Voisin P, Andre JL, Briquel ME, Stoltz JF, Martinet N, Alexandre P (1994) Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy. Nephron 68:184\u2013191","journal-title":"Nephron"},{"key":"3173_CR29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00467-002-0865-7","volume":"17","author":"M Tkaczyk","year":"2002","unstructured":"Tkaczyk M, Baj Z (2002) Surface markers of platelet function in idiopathic nephrotic syndrome in children. Pediatr Nephrol 17:673\u2013677","journal-title":"Pediatr Nephrol"},{"key":"3173_CR30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00467-004-1620-z","volume":"20","author":"AM Wasilewska","year":"2005","unstructured":"Wasilewska AM, Zoch-Zwierz WM, Tomaszewska B, Biernacka A (2005) Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome. Pediatr Nephrol 20:36\u201341","journal-title":"Pediatr Nephrol"},{"key":"3173_CR31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jth.12891","volume":"13","author":"B Eneman","year":"2015","unstructured":"Eneman B, Freson K, van den Heuvel L, van Hoyweghen E, Collard L, Vande Walle J, van Geet C, Levtchenko E (2015) Pituitary adenylate cyclase-activating polypeptide deficiency associated with increased platelet count and aggregability in nephrotic syndrome. J Thromb Haemost 13:755\u2013767","journal-title":"J Thromb Haemost"},{"key":"3173_CR32","first-page":"1647","volume":"7","author":"A Mittal","year":"2013","unstructured":"Mittal A, Aggarwal KC, Saluja S, Aggarwal A, Sureka B (2013) Platelet functions and coagulation changes in Indian children with nephrotic syndrome. J Clin Diagn Res 7:1647\u20131650","journal-title":"J Clin Diagn Res"},{"key":"3173_CR33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/09537104.2012.731111","volume":"24","author":"I Kocyigit","year":"2013","unstructured":"Kocyigit I, Yilmaz MI, Simsek Y, Unal A, Sipahioglu MH, Eroglu E, Dede F, Tokgoz B, Oymak O, Utas C (2013) The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome. Platelets 24:474\u2013479","journal-title":"Platelets"},{"key":"3173_CR34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0049-3848(79)90082-3","volume":"16","author":"G Remuzzi","year":"1979","unstructured":"Remuzzi G, Mecca G, Marchesi D, Livio M, de Gaetano G, Donati MB, Silver MJ (1979) Platelet hyperaggregability and the nephrotic syndrome. Thromb Res 16:345\u2013354","journal-title":"Thromb Res"},{"key":"3173_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.1982.tb03862.x","volume":"52","author":"CA Jackson","year":"1982","unstructured":"Jackson CA, Greaves M, Patterson AD, Brown CB, Preston FE (1982) Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 52:69\u201377","journal-title":"Br J Haematol"},{"key":"3173_CR36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000182895","volume":"33","author":"F Panicucci","year":"1983","unstructured":"Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G, Giovannetti S (1983) Comprehensive study of haemostasis in nephrotic syndrome. Nephron 33:9\u201313","journal-title":"Nephron"},{"key":"3173_CR37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000064282","volume":"91","author":"V Sirolli","year":"2002","unstructured":"Sirolli V, Ballone E, Garofalo D, Merciaro G, Settefrati N, Di Mascio R, Di Gregorio P, Bonomini M (2002) Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests. Nephron 91:424\u2013430","journal-title":"Nephron"},{"key":"3173_CR38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0952-3278(94)90181-3","volume":"51","author":"S Turi","year":"1994","unstructured":"Turi S, Bereczki C, Torday C, Havass Z (1994) Laser aggregometer studies, ATP release and thromboxane B2 release and cAMP concentration of the platelets in nephrotic syndrome. Prostaglandins Leukot Essent Fatty Acids 51:69\u201373","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"3173_CR39","first-page":"651","volume":"81","author":"NU Bang","year":"1973","unstructured":"Bang NU, Trygstad W, Schroeder JE, Heidenreich RO, Csiscko BM (1973) Enhanced platelet function in glomerular renal disease. J Lab Clin Med 81:651\u2013660","journal-title":"J Lab Clin Med"},{"key":"3173_CR40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V55.3.418.418","volume":"55","author":"MJ Stuart","year":"1980","unstructured":"Stuart MJ, Gerrard JM, White JG (1980) The influence of albumin and calcium on human platelet arachidonic acid metabolism. Blood 55:418\u2013423","journal-title":"Blood"},{"key":"3173_CR41","first-page":"659","volume":"32","author":"K Taira","year":"1990","unstructured":"Taira K, Okajima C, Yamashita T, Kawahara S, Matsunaga T, Nakajima M, Kamitsuji H (1990) Ristocetin induced platelet aggregation in children with nephrotic syndrome. Nihon Jinzo Gakkai Shi 32:659\u2013666","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"3173_CR42","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0002-9343(80)90466-0","volume":"69","author":"AJ Adler","year":"1980","unstructured":"Adler AJ, Lundin AP, Feinroth MV, Friedman EA, Berlyne GM (1980) Beta-thromboglobulin levels in the nephrotic syndrome. Am J Med 69:551\u2013554","journal-title":"Am J Med"},{"key":"3173_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00320629","volume":"57","author":"F Goubran","year":"1988","unstructured":"Goubran F, Maklady F (1988) In vivo platelet activity and serum albumin concentration in nephrotic syndrome. Blut 57:15\u201317","journal-title":"Blut"},{"key":"3173_CR44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1442-200x.2005.02078.x","volume":"47","author":"A Wasilewska","year":"2005","unstructured":"Wasilewska A, Zoch-Zwierz WM, Tomaszewska B, Zelazowska B (2005) Relationship of serum interleukin-7 concentration and the coagulation state in children with nephrotic syndrome. Pediatr Int 47:424\u2013429","journal-title":"Pediatr Int"},{"key":"3173_CR45","first-page":"247","volume":"10","author":"K Kilis-Pstrusinska","year":"2001","unstructured":"Kilis-Pstrusinska K, Medynska A, Wikiera-Magott I, Zwolinska D (2001) Levels of selected soluble adhesion molecules in blood serum of children with chronic glomerulonephritis. Pol Merkur Lekarski 10:247\u2013249","journal-title":"Pol Merkur Lekarski"},{"key":"3173_CR46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000190293","volume":"77","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Suzuki J, Watanabe M, Suzuki S, Yoshida K, Kume K, Suzuki H (1997) Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood. Nephron 77:309\u2013314","journal-title":"Nephron"},{"key":"3173_CR47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ki.1984.72","volume":"25","author":"A Schieppati","year":"1984","unstructured":"Schieppati A, Dodesini P, Benigni A, Massazza M, Mecca G, Remuzzi G, Livio M, de Gaetano G, Rossi EC (1984) The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney Int 25:671\u2013676","journal-title":"Kidney Int"},{"key":"3173_CR48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-2143(98)90059-2","volume":"131","author":"AC Matzdorff","year":"1998","unstructured":"Matzdorff AC, Kuhnel G, Kemkes-Matthes B, Pralle H (1998) Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry. J Lab Clin Med 131:507\u2013517","journal-title":"J Lab Clin Med"},{"key":"3173_CR49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/09537100120058810","volume":"12","author":"R Pathansali","year":"2001","unstructured":"Pathansali R, Smith N, Bath P (2001) Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets 12:292\u2013297","journal-title":"Platelets"},{"key":"3173_CR50","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2007-06-098558","volume":"111","author":"K Freson","year":"2008","unstructured":"Freson K, Peeters K, De Vos R, Wittevrongel C, Thys C, Hoylaerts MF, Vermylen J, Van Geet C (2008) PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications. Blood 111:1885\u20131893","journal-title":"Blood"},{"key":"3173_CR51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood.V52.5.969.969","volume":"52","author":"N Yoshida","year":"1978","unstructured":"Yoshida N, Aoki N (1978) Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 52:969\u2013977","journal-title":"Blood"},{"key":"3173_CR52","first-page":"229","volume":"15","author":"U Kuhlmann","year":"1981","unstructured":"Kuhlmann U, Steurer J, Rhyner K, von Felten A, Briner J, Siegenthaler W (1981) Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis. Clin Nephrol 15:229\u2013235","journal-title":"Clin Nephrol"},{"key":"3173_CR53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000186178","volume":"56","author":"N Ueda","year":"1990","unstructured":"Ueda N (1990) Effect of corticosteroids on some hemostatic parameters in children with minimal change nephrotic syndrome. Nephron 56:374\u2013378","journal-title":"Nephron"},{"key":"3173_CR54","first-page":"59","volume":"4","author":"SJ Shattil","year":"1978","unstructured":"Shattil SJ, Cooper RA (1978) Role of membrane lipid composition, organization, and fluidity in human platelet function. Prog Hemost Thromb 4:59\u201386","journal-title":"Prog Hemost Thromb"},{"key":"3173_CR55","doi-asserted-by":"crossref","unstructured":"Gerrard JM (1988) Platelet aggregation: cellular regulation and physiologic role. Hosp Pract (Off Ed) 23:89\u201398, 103\u2013104, 107\u2013108","DOI":"10.1080\/21548331.1988.11703404"},{"key":"3173_CR56","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/ndt\/gfr476","volume":"27","author":"H Akoglu","year":"2012","unstructured":"Akoglu H, Agbaht K, Piskinpasa S, Falay MY, Dede F, Ozet G, Odabas AR (2012) High frequency of aspirin resistance in patients with nephrotic syndrome. Nephrol Dial Transplant 27:1460\u20131466","journal-title":"Nephrol Dial Transplant"},{"key":"3173_CR57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-996100","volume":"23","author":"N Schlegel","year":"1997","unstructured":"Schlegel N (1997) Thromboembolic risks and complications in nephrotic children. Semin Thromb Hemost 23:271\u2013280","journal-title":"Semin Thromb Hemost"},{"key":"3173_CR58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI200419252","volume":"113","author":"K Freson","year":"2004","unstructured":"Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, Shintani N, Tomiyama Y, Vermylen J, Hoylaerts MF, Baba A, Van Geet C (2004) The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest 113:905\u2013912","journal-title":"J Clin Invest"},{"key":"3173_CR59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","volume":"155","author":"BA Kerlin","year":"2009","unstructured":"Kerlin BA, Blatt NB, Fuh B, Zhao S, Lehman A, Blanchong C, Mahan JD, Smoyer WE (2009) Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr 155:105\u2013110, 110 e101","journal-title":"J Pediatr"},{"key":"3173_CR60","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1161\/CIRCULATIONAHA.104.494468","volume":"112","author":"JE Freedman","year":"2005","unstructured":"Freedman JE (2005) Molecular regulation of platelet-dependent thrombosis. Circulation 112:2725\u20132734","journal-title":"Circulation"},{"key":"3173_CR61","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jth.12728","volume":"12","author":"A Undas","year":"2014","unstructured":"Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost 12:1776\u20131787","journal-title":"J Thromb Haemost"},{"key":"3173_CR62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.blre.2014.03.003","volume":"28","author":"C Becattini","year":"2014","unstructured":"Becattini C, Agnelli G (2014) Aspirin for prevention and treatment of venous thromboembolism. Blood Rev 28:103\u2013108","journal-title":"Blood Rev"},{"key":"3173_CR63","first-page":"1","volume":"13","author":"J Riedl","year":"2015","unstructured":"Riedl J, Hell L, Kaider A, Koder S, Marosi C, Zielinski C, Panzer S, Pabinger I, Ay C (2015) Association of platelet activation markers with cancer-associated venous thromboembolism. Platelets 13:1\u20136","journal-title":"Platelets"},{"key":"3173_CR64","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","volume":"8","author":"R Simanek","year":"2010","unstructured":"Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I, Steger G, Jaeger U, Zielinski C, Pabinger I (2010) High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 8:114\u2013120","journal-title":"J Thromb Haemost"},{"key":"3173_CR65","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1538-7836.2004.00991.x","volume":"2","author":"NA Zakai","year":"2004","unstructured":"Zakai NA, Wright J, Cushman M (2004) Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost 2:2156\u20132161","journal-title":"J Thromb Haemost"},{"key":"3173_CR66","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00467-013-2525-5","volume":"29","author":"BA Kerlin","year":"2014","unstructured":"Kerlin BA, Haworth K, Smoyer WE (2014) Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol 29:989\u2013997","journal-title":"Pediatr Nephrol"},{"key":"3173_CR67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jpeds.2011.03.052","volume":"159","author":"R Tuckuviene","year":"2011","unstructured":"Tuckuviene R, Christensen AL, Helgestad J, Johnsen SP, Kristensen SR (2011) Pediatric venous and arterial noncerebral thromboembolism in Denmark: a nationwide population-based study. J Pediatr 159:663\u2013669","journal-title":"J Pediatr"},{"key":"3173_CR68","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1083\/jcb.200105058","volume":"154","author":"S Lindemann","year":"2001","unstructured":"Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154:485\u2013490","journal-title":"J Cell Biol"},{"key":"3173_CR69","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.ATV.0000095974.95122.EC","volume":"23","author":"DD Wagner","year":"2003","unstructured":"Wagner DD, Burger PC (2003) Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23:2131\u20132137","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3173_CR70","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00005-009-0032-y","volume":"57","author":"JM Sowa","year":"2009","unstructured":"Sowa JM, Crist SA, Ratliff TL, Elzey BD (2009) Platelet influence on T- and B-cell responses. Arch Immunol Ther Exp (Warsz) 57:235\u2013241","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"3173_CR71","first-page":"81","volume":"632","author":"EI Peerschke","year":"2008","unstructured":"Peerschke EI, Yin W, Ghebrehiwet B (2008) Platelet mediated complement activation. Adv Exp Med Biol 632:81\u201391","journal-title":"Adv Exp Med Biol"},{"key":"3173_CR72","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000190313","volume":"77","author":"JL Barnes","year":"1997","unstructured":"Barnes JL (1997) Platelets in glomerular disease. Nephron 77:378\u2013393","journal-title":"Nephron"},{"key":"3173_CR73","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00866739","volume":"9","author":"C Zoja","year":"1995","unstructured":"Zoja C, Remuzzi G (1995) Role of platelets in progressive glomerular diseases. Pediatr Nephrol 9:495\u2013502","journal-title":"Pediatr Nephrol"},{"key":"3173_CR74","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/37.7.2659663","volume":"37","author":"JL Barnes","year":"1989","unstructured":"Barnes JL (1989) Glomerular localization of platelet secretory proteins in mesangial proliferative lesions induced by habu snake venom. J Histochem Cytochem 37:1075\u20131082","journal-title":"J Histochem Cytochem"},{"key":"3173_CR75","first-page":"755","volume":"63","author":"J Barnes","year":"1990","unstructured":"Barnes J, Camussi G, Tetta C, Venkatachalam MA (1990) Glomerular localization of platelet cationic proteins after immune complex-induced platelet activation. Lab Invest 63:755\u2013761","journal-title":"Lab Invest"},{"key":"3173_CR76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-014-0065-5","volume":"7","author":"S Rachidi","year":"2014","unstructured":"Rachidi S, Wallace K, Day TA, Alberg AJ, Li Z (2014) Lower circulating platelet count and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol 7:65","journal-title":"J Hematol Oncol"},{"key":"3173_CR77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0032-1328881","volume":"38","author":"RE Scharf","year":"2012","unstructured":"Scharf RE (2012) Drugs that affect platelet function. Semin Thromb Hemost 38:865\u2013883","journal-title":"Semin Thromb Hemost"},{"key":"3173_CR78","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00849225","volume":"1","author":"N Ueda","year":"1987","unstructured":"Ueda N, Kawaguchi S, Niinomi Y, Nonoda T, Matsumoto J, Ohnishi M, Yasaki T (1987) Effect of corticosteroids on coagulation factors in children with nephrotic syndrome. Pediatr Nephrol 1:286\u2013289","journal-title":"Pediatr Nephrol"},{"key":"3173_CR79","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","volume":"106","author":"LA Moraes","year":"2005","unstructured":"Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M (2005) Ligand-specific glucocorticoid receptor activation in human platelets. Blood 106:4167\u20134175","journal-title":"Blood"},{"key":"3173_CR80","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.bcp.2012.02.006","volume":"83","author":"E Liverani","year":"2012","unstructured":"Liverani E, Banerjee S, Roberts W, Naseem KM, Perretti M (2012) Prednisolone exerts exquisite inhibitory properties on platelet functions. Biochem Pharmacol 83:1364\u20131373","journal-title":"Biochem Pharmacol"},{"key":"3173_CR81","first-page":"218","volume":"76","author":"G Sahin","year":"2011","unstructured":"Sahin G, Akay OM, Bal C, Yalcin AU, Gulbas Z (2011) The effect of calcineurin inhibitors on endothelial and platelet function in renal transplant patients. Clin Nephrol 76:218\u2013225","journal-title":"Clin Nephrol"},{"key":"3173_CR82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199101033240106","volume":"324","author":"JN George","year":"1991","unstructured":"George JN, Shattil SJ (1991) The clinical importance of acquired abnormalities of platelet function. N Engl J Med 324:27\u201339","journal-title":"N Engl J Med"},{"key":"3173_CR83","first-page":"359","volume":"4","author":"G Escolar","year":"2005","unstructured":"Escolar G, Diaz-Ricart M, Cases A (2005) Uremic platelet dysfunction: past and present. Curr Hematol Rep 4:359\u2013367","journal-title":"Curr Hematol Rep"},{"key":"3173_CR84","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1345\/aph.1R530","volume":"47","author":"KJ Pincus","year":"2013","unstructured":"Pincus KJ, Hynicka LM (2013) Prophylaxis of thromboembolic events in patients with nephrotic syndrome. Ann Pharmacother 47:725\u2013734","journal-title":"Ann Pharmacother"},{"key":"3173_CR85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00128072-200305050-00006","volume":"5","author":"E Hodson","year":"2003","unstructured":"Hodson E (2003) The management of idiopathic nephrotic syndrome in children. Paediatr Drugs 5:335\u2013349","journal-title":"Paediatr Drugs"},{"key":"3173_CR86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-9343(86)90909-5","volume":"81","author":"C Patrono","year":"1986","unstructured":"Patrono C, Pierucci A (1986) Renal effects of nonsteroidal anti-inflammatory drugs in chronic glomerular disease. Am J Med 81:71\u201383","journal-title":"Am J Med"},{"key":"3173_CR87","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05329.x","volume":"129","author":"C Dame","year":"2005","unstructured":"Dame C, Sutor AH (2005) Primary and secondary thrombocytosis in childhood. Br J Haematol 129:165\u2013177","journal-title":"Br J Haematol"},{"key":"3173_CR88","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00467-012-2376-5","volume":"28","author":"I Simic","year":"2013","unstructured":"Simic I, Tabatabaeifar M, Schaefer F (2013) Animal models of nephrotic syndrome. Pediatr Nephrol 28:2079\u20132088","journal-title":"Pediatr Nephrol"},{"key":"3173_CR89","first-page":"209","volume":"98","author":"F Goubran","year":"1986","unstructured":"Goubran F, Maklady F, Saad M, el Ashry M (1986) In vivo platelet activity and lipoprotein patterns in coronary artery disease. Wien Klin Wochenschr 98:209\u2013211","journal-title":"Wien Klin Wochenschr"},{"key":"3173_CR90","first-page":"380","volume":"44","author":"K Takagawa","year":"2002","unstructured":"Takagawa K, Nakajima M, Taira K, Sakagami Y, Ueda T, Akazawa H, Maruhashi Y, Shimoyama H, Takahashi Y, Fujimura Y, Kamitsuji H, Yoshioka A (2002) Shear stress-induced platelet aggregation in children with minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 44:380\u2013388","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"3173_CR91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1172\/JCI116947","volume":"93","author":"JJ Zwaginga","year":"1994","unstructured":"Zwaginga JJ, Koomans HA, Sixma JJ, Rabelink TJ (1994) Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. J Clin Invest 93:204\u2013211","journal-title":"J Clin Invest"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3173-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3173-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3173-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T23:22:29Z","timestamp":1599434549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3173-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3173-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]}}}